Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives ...

ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer ...

uniQure is planning to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162, its one-time gene therapy for amyotrophic lateral sclerosis (ALS) associated with ...

Lupin’s Somerset, New Jersey manufacturing facility received a clean report from the US FDA after a pre-approval inspection of Edaravone oral suspension, conducted between January 28 and February 1, ...

At 2 years, more untreated controls died than those treated with IV edaravone. Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection (PAI) of Edaravone Oral Suspension, 105 ...

Global pharma major Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has completed a pre-approval inspection (PAI) of edaravone oral suspension, 105 mg/ 5 mL ...

"Global pharma major Lupin Limited today announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection (PAI) of Edaravone Oral Suspension, 105 mg/ 5 ...

With zero observations, the US FDA has completed a pre-approval inspection of Edaravone oral suspension at its Somerset, New Jersey manufacturing facility. The inspection took place from January ...

The company announced completion of a pre-approval inspection by the USFDA of Edaravone Oral Suspension, 105 mg/ 5 mL at the manufacturing facility in Somerset, New Jersey. The inspection was ...